Emergent BioSolutions Reports First Quarter 2019 Financial Results
Reaffirms full year 2019 financial forecast and operational goals Provides Q2 2019 revenue forecast of $200M-$220M GAITHERSBURG, Md., May 02, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the three months …